WGS
GeneDx Holdings Corp.
Next earnings Jul 27, 2026 · consensus $-0.06 EPS, $116M rev
Last earnings +3.9% on 2026-05-04
$63.54
▲ +9.40%$63.54▼ -1.38%
over 1Y
L $34.51EODHDH $167.52
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+9.4%
1W+12.6%
1M+28.5%
3M-5.1%
YTD-52.0%
1Y-1.4%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 13 analysts
Buy
Revenue grew 40.0% YoY; but unprofitable (net margin -4.9%).
GeneDx Holdings Corp. shows $428M in FY2025 revenue (+40.0% YoY), a -4.9% net margin, and -6.8% ROE.
Sources: SEC EDGAR (CIK 0001818331, latest 10-Q filed 2026-05-04) · EODHD · as of 6/25/2026, 7:24:00 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.